NCT06825286View on ClinicalTrials.gov

Dexmedetomidine as an Adjuvant to Bupivacaine in Ultrasound-Guided Quadratus Lumborum Block for Postoperative Analgesia in Laparoscopic Cholecystectomy

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

August 1, 2024

Study Completion Date

August 1, 2024

Conditions
DexmedetomidineBupivacaineUltrasound-GuidedQuadratus Lumborum BlockPostoperative AnalgesiaLaparoscopic Cholecystectomy
Interventions
DRUG

Bupivacaine

Patients received general anesthesia and bilateral ultrasound guided transmuscular quadratus lumborum block wilh (20 ml bupivacaine 0.25%).

DRUG

Bupivacaine and Dexmedetomidinc) group

Patients received general anesthesia and bilateral ultrasound guided transmuscular quadratus lumborum block with (20ml Bupivacaine 0.25%) + (Dexmedetomidine Imic/kg)

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06825286 - Dexmedetomidine as an Adjuvant to Bupivacaine in Ultrasound-Guided Quadratus Lumborum Block for Postoperative Analgesia in Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter